Encision
Encision Inc. is a Boulder, Colorado medical device company that develops AEM® Active Electrode Monitoring laparoscopic surgical instruments designed to eliminate stray energy burns, selling capital equipment and disposable/reposable instruments to US hospitals via GPO contracts and licensing to surgical robotics partners.
- Company typePublic
- Founded1991
- HeadquartersBoulder, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Encision does
Encision Inc. is a Boulder, Colorado-based medical device company founded in 1991 that develops and manufactures Active Electrode Monitoring (AEM®) technology and laparoscopic surgical instruments designed to eliminate stray energy burns to patients during minimally invasive surgery. The company's core technology — AEM® — electrically shields the laparoscopic instrument shaft and continuously monitors insulation integrity during use, automatically shutting down the electrosurgical generator when an insulation fault or capacitive coupling is detected. Its product portfolio includes the AEM EndoShield® 2 Burn Protection System (capital equipment, FDA 510(k) cleared June 2014), AEM enTouch® Reposable 2x Scissors, AEM e-Edge® disposable scissors, AEM Shield™ laparoscopic instruments, the EM3 Burn Protection Monitor (discontinued February 2026), and PowerGrip® bipolar instruments. The company also offers a distinctive 100% Hold Harmless Indemnity Guarantee to physicians and hospitals using AEM instrumentation.
Encision monetizes through three primary revenue streams: (1) one-time capital equipment sales of AEM monitors/burn protection systems to hospitals; (2) recurring disposable and reposable instrument sales (consumables such as electrodes, cables, scissors and sheaths); and (3) licensing/supply arrangements with surgical robotics companies including Intuitive Surgical (2009), Auris Health / J&J (2021), Human Xtensions (2023), and Vicarious Surgical (2023 PoC / 2024 MSA). Pricing is quote-based and not publicly disclosed; sales are handled via direct enterprise outreach out of Boulder, CO headquarters to US hospitals, supplemented by international channel partners Gytech PTY LTD (Australia) and Obex (New Zealand), and GPO contracts with Vizient (Second-Generation Innovative Technology Contract MS1306, covering ~97% of US academic medical centers and ~60% of acute care hospitals), Premier and HealthTrust. Encision was previously listed on AMEX (2004), moved to OTC Bulletin Board (2008), traded as ECIA on OTC US, and voluntarily deregistered from the SEC via Form 15 in January 2026 to pursue quotation on OTC Markets.
Recent financial performance shows a declining revenue trajectory attributed by management to Intuitive Surgical's robots displacing procedures that historically used AEM instrumentation: Q4 FY2026 net sales were $1,241K, down 12% sequentially from $1,413K in Q3 FY2026 and from $1,528K in Q2 FY2026. The company narrowed its Q4 FY2026 net loss to $96K (from $314K in Q3) and improved gross margin by 9.3 percentage points to 47.7% following a completed restructuring that reduced operating expenses by 22.6% and produced operating profitability in March. A $500,000 private placement completed August 19, 2025 is funding development of a new ENT (Ear, Nose and Throat) device planned for early 2026. CEO Gregory Trudel resigned in December 2025 after 12 years amid disagreement over company direction, and Robert Fries was appointed interim President and CEO.
Encision firmographics
Firmographics- Name
- Encision
- Legal name
- Encision Inc.
- Website
- https://encision.com
- Company type
- Public
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Encision Inc. is a Boulder, Colorado medical device company that develops AEM® Active Electrode Monitoring laparoscopic surgical instruments designed to eliminate stray energy burns, selling capital equipment and disposable/reposable instruments to US hospitals via GPO contracts and licensing to surgical robotics partners.
- Ownership category
- akta.pro rank
Encision industry classification
Industry- Product category
- Surgical Instruments — Electrosurgical Burn Protection Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)
- akta.pro secondary industry
- Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)
Keywords
Where Encision is headquartered
LocationHeadquarters
- HQ city
- Boulder
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Encision business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Capital Equipment Sales (AEM Monitors / Burn Protection Systems): One-time sale of AEM EndoShield® 2 Burn Protection System (catalog #EM200) and previously the EM3 AEM Monitor. Sold as reusable capital equipment to hospitals.
- Disposable & Reposable Instrument Sales: Recurring and repeat revenue from disposable AEM electrodes, AEM Burn Protection Cables (ES6107+), disposable e-Edge scissors, disposable sheath, and reposable enTouch 2x Scissors (2 uses per unit). Catalog products include ES0000-series and ES0100-series instruments.
- Licensing, Supply & OEM Relationships: Manufacturing, supply, and licensing arrangements with surgical robotics and medical device partners (Intuitive Surgical 2009; Auris Health 2021; Human Xtensions 2023; Vicarious Surgical 2023 PoC and 2024 MSA) — generating licensing/royalty or supply revenue tied to AEM technology.
- Equity / Private Placement Capital Raises: Non-operating capital raises via private placement of common stock (e.g., $500,000 placement completed August 19, 2025) used to fund new product development (ENT device) and sales.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Quote-based, not publicly listed — hospitals schedule a Free Clinical Evaluation |
| Unit Pricing | — | Unit pricing on consumables and instruments (sold by the box / case) |
| Other | — | Value-based pricing anchored on 100% Hold Harmless Indemnity Guarantee |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels7 records
Encision product offering
Product offeringCore offering
Encision develops, manufactures, and sells proprietary AEM® (Active Electrode Monitoring) laparoscopic surgical instruments and burn protection systems designed to eliminate stray energy burns during monopolar electrosurgery. Its product line includes capital equipment (AEM EndoShield® 2 Burn Protection System), reusable, reposable, and disposable shielded laparoscopic instruments (electrodes, scissors, graspers, sheaths), and burn protection cables, sold primarily to US hospitals and surgical centers through direct sales, GPO contracts, and international distributors.
Differentiator
Problem solved
Functional benefit
Brands
- AEM® Shield™: Encision's branded line of shielded AEM® laparoscopic surgical instruments designed to eliminate stray energy burns during minimally invasive surgery; awarded a Vizient Innovative Technology Contract.
- AEM EndoShield® / AEM EndoShield® 2 Burn Protection System
- AEM enTouch®
- AEM e-Edge®
- AEM® EM3 Burn Protection Monitor
- PowerGrip®
- e·Access™
Products and services
- AEM EndoShield® 2 Burn Protection System Plug-and-play smart cord / monitor that serves as the hub of the AEM system, interfacing with AEM instruments and ESU generators to actively monitor insulation and prevent stray energy burns. Catalog #EM200. Sold as reusable capital equipment to hospitals.
- AEM® EM3 Burn Protection Monitor Plug-and-play AEM monitor with integrated hand control, compatible with popular electrosurgical units (ESUs) via adapters (Olympus, Conmed). The EM3 Product Family was discontinued as of February 2026.
- AEM® Shield™ Laparoscopic Instruments Shielded AEM® laparoscopic surgical instruments (electrodes, graspers, dissectors) that actively monitor the active electrode during minimally invasive surgery and shut down the electrosurgical generator if an insulation fault or dangerous capacitive coupling is detected. Includes AEM Reusable, Disposable, and Reposable instruments in the ES0000-series and ES0100-series catalog.
- AEM enTouch® Reposable 2x Scissors Reposable (2-use) laparoscopic scissors with micro-serrated blades, color indicators showing when to replace, and a high-performance AEM enTouch® handle with tactile feedback. Designed to be sharp, responsive, and to reduce cost and waste.
- AEM e-Edge® Disposable Scissors
Quantifiable outcome
- Patient burned every 90 minutes in the USA during laparoscopic surgery (marketing-cited; 1–2 patient deaths per day) — AEM technology positioned to eliminate these.
- +3 more outcomes
Companies that use Encision
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Encision technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Encision partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered high — robotics co-development relationship (poc feb 2023; msa aug 2024), core — supplier agreement for handheld surgical robotics, high — supply relationship with a johnson & johnson surgical robotics subsidiary, flagship — second-generation contract (ms1306) covers 97% of us academic medical centers and 60% of acute care hospitals, minor — exclusive distribution agreement (older), core — gpo purchasing agreement for member hospitals, high — long-running non-exclusive manufacturing, supply and licensing agreement with the market-leading surgical robotics company, minor — sales representation agreement, core — extended gpo supplier agreement for member hospitals, core — exclusive australia distribution channel, core — new zealand distribution channel, core — co-developer of accredited nursing continuing education, minor — administrative service provider, core — clinical practice guideline endorsement, core — clinical society endorsement and historical — encision deregistered in 2026.
- Vicarious Surgical Inc.high — robotics co-development relationship (poc feb 2023; msa aug 2024)Signed a Master Services Agreement on August 21, 2024, following a Proof-of-Concept Agreement signed February 14, 2023. Vicarious Surgical is a robotics company; the relationship appears aimed at integrating Encision's AEM technology into next-generation surgical robotics platforms.
- Human Xtensionscore — supplier agreement for handheld surgical roboticsSupplier Agreement signed February 28, 2023, with Human Xtensions, an Israel-based developer of handheld surgical robotics. Encision supplies AEM technology/components for integration.
- Auris Health, Inc.high — supply relationship with a johnson & johnson surgical robotics subsidiarySupply Agreement signed August 24, 2021. Auris Health (a J&J subsidiary focused on surgical robotics, including the Monarch platform) is supplied by Encision under this agreement. Form 8-K filings in 2020 also reference Auris.
- Vizientflagship — second-generation contract (ms1306) covers 97% of us academic medical centers and 60% of acute care hospitalsEncision's AEM® Shield™ Laparoscopic Instruments received a Vizient Innovative Technology Contract (initial April 2, 2019), later renewed as a Second-Generation Innovative Technology Contract (MS1306). Vizient is the nation's leading healthcare improvement company, and the contract is based on a member-led hospital expert council recommendation. There is no other technology on the market providing the same patient-safety, performance and value combination.
- Virtual Ports Ltd.minor — exclusive distribution agreement (older)Exclusive Distribution Agreement for Laparoscopic Surgery Devices announced April 16, 2013, between Encision Inc. and Virtual Ports Ltd.
- HealthTrust Purchasing Groupcore — gpo purchasing agreement for member hospitalsPurchasing Agreement signed June 1, 2010, between Encision and HealthTrust Purchasing Group, a healthcare GPO serving member hospitals.
- Intuitive Surgicalhigh — long-running non-exclusive manufacturing, supply and licensing agreement with the market-leading surgical robotics companyNon-Exclusive Manufacturing, Supply and Licensing Agreement signed April 8, 2009. Encision's Q3/Q4 FY2026 earnings commentary noted that Intuitive Surgical's robots are replacing procedures that historically used Encision's AEM instrumentation, suggesting the relationship has shifted to one where Intuitive increasingly captures the procedure volume.
- Caldera Medicalminor — sales representation agreementSales Representation Agreement signed March 25, 2009, between Encision and Caldera Medical.
- Premiercore — extended gpo supplier agreement for member hospitalsSupplier Agreement extended June 17, 2004. Premier is a major healthcare GPO; the relationship covers Encision's AEM Surgical Instruments for Premier member hospitals.
- Gytech PTY LTDcore — exclusive australia distribution channelAustralian distribution partner. Janet Padgham serves as Director of Sales ([email protected], www.gytech.com.au). Listed as Encision's Australia contact on the official Sales page.
- Obexcore — new zealand distribution channelNew Zealand distribution partner. Contact: [email protected], Ph 09-630-3456, Fax 09-630-9009. Listed as Encision's New Zealand contact on the official Sales page.
- Pfiedler Education (Pfiedler Enterprises)core — co-developer of accredited nursing continuing educationPfiedler Education developed the 'Safer Surgery Together' virtual CE course on behalf of / with Encision. The course is free for local AORN chapters and coworkers, delivered in person or via Zoom for 2 nursing contact hours. Pfiedler Enterprises is a California Board of Nursing approved provider (Provider Number CEP 13019).
- Computershareminor — administrative service providerComputershare serves as Encision's Transfer Agent. Mailing address: P.O. Box 43006, Providence, RI 02940-3006. Courier delivery: 150 Royall St., Suite 101, Canton, MA 02021.
- AORN (Association of periOperative Registered Nurses)core — clinical practice guideline endorsementEncision's AEM technology has been cited in AORN Recommended Practices and the AORN Electrosurgical Safety Guideline, which recommends use of an Active Electrode Monitoring (AEM®) and Shielding Device during minimally invasive surgery. Encision offers free continuing education to AORN chapter members.
- SAGES (Society of American Gastrointestinal and Endoscopic Surgeons)core — clinical society endorsementAEM technology was presented at SAGES (April 7, 2004) and is cited as a recommended practice of SAGES for electrosurgical safety (per EM3 Monitor product page). Encision participated in the 2010 Minimally Invasive Gynecology Congress.
- AAGL (American Association of Gynecologic Laparoscopists)core — clinical society endorsementEncision's AEM technology has been presented at AAGL (November 17, 2005; 2010) and is cited as a recommended practice of AAGL for electrosurgical safety (per EM3 Monitor product page).
- SEC (Securities and Exchange Commission)historical — encision deregistered in 2026Encision filed a Form 15 with the SEC in January 2026 (Form 15-12G filed 01/29/2026; Form 15-12G/A filed 06/10/2026) to voluntarily deregister its common stock under Section 12(g) of the Securities Exchange Act of 1934. SEC EDGAR CIK 0000930775. Trading halted and OTC Markets application initiated.
Scale indicators10 records
Recent moves7 records
Expansion highlights5 records
Encision competitors and assessment
Company assessmentDirect peers
- CONMED Corporation: Specialist in electrosurgical generators, smoke evacuation and laparoscopic instruments; also referenced as an Encision EM3 compatibility partner. Closely comparable in product scope (electrosurgery + laparoscopy) and target customer (hospital ORs).
- Applied Medical Resources: Privately-held developer and manufacturer of laparoscopic surgical instruments, trocars, and energy devices focused on patient safety and cost. Closely aligned with Encision in target market (US hospitals) and emphasis on clinical-economics-driven value propositions.
- Erbe Elektromedizin: German specialist in electrosurgical generators and instruments, including vessel-sealing and monopolar/bipolar systems for minimally invasive surgery. Closely comparable technology footprint to Encision's AEM line and active in the same electrosurgery-safety narrative.
Broad incumbents
- B. Braun (Aesculap): Major surgical instruments manufacturer (Aesculap division) supplying laparoscopic and electrosurgical instruments globally. Comparable in hospital-channel sales motion and reusable/reposable instrument mix.
- Stryker Corporation: Large diversified surgical device maker with a significant surgical instruments and energy platform. Comparable buyer/customer profile (hospitals, IDNs, GPOs) and overlaps with Encision in monopolar/bipolar laparoscopic instrumentation.
- Medtronic: Diversified medtech giant with a broad surgical instruments and electrosurgery portfolio (including the Valleylab energy franchise). Sells laparoscopic instruments and electrosurgical generators that compete for the same OR budget as Encision's AEM products.
- Intuitive Surgical: Market-leading robotic surgical platform (da Vinci) and a long-time Encision OEM partner (2009 licensing agreement). Direct overlap in laparoscopic electrosurgical delivery and the principal disruptor cited by Encision management as causing procedure-volume displacement.
- Johnson & Johnson (Ethicon / Auris Health): Ethicon supplies surgical instruments and energy devices; Auris Health (J&J subsidiary, Monarch platform) signed an Encision supply agreement in 2021. Comparable as both an electrosurgical competitor and an OEM/licensing counterparty.
- Olympus Corporation: Major manufacturer of laparoscopic surgical instruments and electrosurgical generators referenced as an EM3 compatibility partner. Competes with Encision in reusable laparoscopic instrument market segments and bundled OR solutions.
Emerging players
- Vicarious Surgical: Early-stage surgical robotics company that signed a Master Services Agreement with Encision in August 2024 (after a 2023 PoC). Relevant both as a direct OEM/licensing partner comparable to the relationship dynamic Encision has with Intuitive and as a peer in adjacent surgical robotics commercialization.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Encision social profiles
Digital presenceEncision financial estimates
Financial estimateRevenue estimate
Valuation estimate
Encision leadership team
Management profileNumber of profiles
Profiles6 records
Encision funding detail
Funding detailFunding overview
Funding rounds4 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Encision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Encision
What does Encision do?
Encision develops, manufactures, and sells proprietary AEM® (Active Electrode Monitoring) laparoscopic surgical instruments and burn protection systems designed to eliminate stray energy burns during monopolar electrosurgery. Its product line includes capital equipment (AEM EndoShield® 2 Burn Protection System), reusable, reposable, and disposable shielded laparoscopic instruments (electrodes, scissors, graspers, sheaths), and burn protection cables, sold primarily to US hospitals and surgical centers through direct sales, GPO contracts, and international distributors.
Is Encision a public or private company?
Encision is a public company. It is classified as public and is currently operating.
When was Encision founded?
Encision was founded in 1991. It employs 51 to 100 people.
Where is Encision based?
Encision is headquartered in Boulder, United States, in the North America region.
How does Encision make money?
Four revenue lines are on record. Capital Equipment Sales (AEM Monitors / Burn Protection Systems) is the primary driver. The others are disposable & Reposable Instrument Sales, licensing, Supply & OEM Relationships and equity / Private Placement Capital Raises.
Who are Encision's main competitors?
Direct peers on record are CONMED Corporation, Applied Medical Resources and Erbe Elektromedizin. Broad incumbents are B. Braun (Aesculap), Stryker Corporation, Medtronic, Intuitive Surgical, Johnson & Johnson (Ethicon / Auris Health) and Olympus Corporation. Vicarious Surgical is listed as an emerging player.
Does Encision have an API?
No public API is recorded for Encision.
What industry is Encision in?
Encision's product category is Surgical Instruments — Electrosurgical Burn Protection Devices. Its primary akta.pro industry code is HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser), with a secondary code of HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits). Its NAICS code is 339112 and its SIC code is 3841.